Hydrochlorothiazide inhibits bone resorption in men despite experimentally elevated serum 1,25-dihydroxyvitamin D concentrations

Kidney Int. 1985 Dec;28(6):951-8. doi: 10.1038/ki.1985.223.

Abstract

We evaluated the effects of hydrochlorothiazide administration in relation to Ca balance, the PTH and vitamin D endocrine systems, acid-base balance, and bone. We studied six healthy men fed constant diets providing only 5.1 +/- 0.7 SD mmoles Ca/day. Three of the men were also given calcitriol, 0.5 microgram 6-hrly throughout their studies. All subjects were observed during 18 control days and then during 18 days of hydrochlorothiazide (HTZ) administration, 25 mg 12-hrly. Observations during control days 11 through 16 were compared to those during days 7 through 18 of HTZ administration, inclusively. Directional changes during HTZ did not differ among subjects not given or given calcitriol. For all six subjects, control net intestinal Ca absorption, serum 1,25-(OH)2-D concentrations, serum iPTH concentrations, and daily urine cAMP excretion averaged 0.5 +/- 2.2 mmoles/day, 162 +/- 51 pM, 4.3 +/- 2.2 microliter Eq/ml and 4.2 +/- 0.9 mumoles/day, respectively; none changed during HTZ. As expected, HTZ administration was accompanied by a fall in urinary Ca excretion, averaging -1.4 +/- 0.8 mmoles/day; P less than 0.01. HTZ administration was also accompanied by less negative Ca balances, averaging +1.6 +/- 1.0 mmoles/day; P less than 0.025, and by a fall in daily urinary hydroxyproline excretion averaging -0.13 +/- 0.09 mmoles/day; P less than 0.025. We interpret these data to indicate that HTZ administration is accompanied by an inhibition of bone resorption. HTZ administration also raised serum HCO3 concentrations by +2.7 +/- 0.5 mEq/liter; P less than 0.001 and blood pH by + 0.05 +/- 0.02 units; P less than 0.005.(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acid-Base Equilibrium
  • Adult
  • Bicarbonates / blood
  • Body Weight
  • Bone Resorption / drug effects*
  • Calcitriol / blood
  • Calcium / metabolism*
  • Creatinine / metabolism
  • Cyclic AMP / urine
  • Diuresis
  • Homeostasis / drug effects
  • Humans
  • Hydrochlorothiazide / pharmacology*
  • Hydrogen-Ion Concentration
  • Hydroxyproline / urine
  • Intestinal Absorption
  • Male
  • Minerals / metabolism
  • Oxalates / urine
  • Parathyroid Hormone / blood
  • Potassium / metabolism
  • Sodium / metabolism

Substances

  • Bicarbonates
  • Minerals
  • Oxalates
  • Parathyroid Hormone
  • Hydrochlorothiazide
  • Sodium
  • Creatinine
  • Cyclic AMP
  • Calcitriol
  • Hydroxyproline
  • Potassium
  • Calcium